GLP-1 Medications for Weight Loss Now Available!

The state of Texas currently has 2 active clinical trials seeking participants for Weight Loss research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Recruiting
This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm dose-finding study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 Oral Formulation in adults who are obese (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. VK2735 or matched placebo will be administered once daily.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/19/2025
Locations: Viking Clinical Site #104, Austin, Texas +1 locations
Conditions: Weight Loss
Financial Coaching and Lifestyle Intervention for Diabetes Prevention in Low-income Families
Recruiting
The purpose of this study is to compare the effect on weight and metabolic outcomes of an enhanced intervention, comprised of evidence-based financial coaching plus a lifestyle intervention vs. the lifestyle intervention alone
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/05/2023
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Weight Loss